share_log

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.

Panbela Therapeutics | 4：持股變動聲明-高管 Simpson Jennifer K.
美股SEC公告 ·  10/03 16:32

Moomoo AI 已提取核心訊息

Jennifer K. Simpson, President and CEO of Panbela Therapeutics, Inc. [PBLA], was reported to have engaged in a transaction involving the company's stock on October 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report did not include information on the number of shares held by Simpson after the action.
Jennifer K. Simpson, President and CEO of Panbela Therapeutics, Inc. [PBLA], was reported to have engaged in a transaction involving the company's stock on October 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report did not include information on the number of shares held by Simpson after the action.
據報道，Panbela Therapeutics, Inc. [PBLA]的總裁兼首席執行官Jennifer K. Simpson涉嫌在2024年10月1日進行了一筆涉及公司股票的交易。 公告中未披露交易的具體細節，包括股份數量、股份性質、交易價格以及股份的總價值。 交易的類型和狀態也未提供。 報告未提及交易後Simpson持有的股份數量。
據報道，Panbela Therapeutics, Inc. [PBLA]的總裁兼首席執行官Jennifer K. Simpson涉嫌在2024年10月1日進行了一筆涉及公司股票的交易。 公告中未披露交易的具體細節，包括股份數量、股份性質、交易價格以及股份的總價值。 交易的類型和狀態也未提供。 報告未提及交易後Simpson持有的股份數量。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間